September 24, 2025 |
Inizio has appointed Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer, strengthening its executive leadership to drive innovation, digital transformation, and Intelligent Commercialization™ across the health and life sciences sector.

We are proud to announce the strategic appointment of two senior executives to our leadership team – advancing innovation, operational excellence, and digital transformation across the organization.Â
Joining the Executive Team are Mary-Kate McGarry as Chief Strategy & Innovation Officer and Gavin McShera as Chief Information Officer. These appointments strengthen our ability to deliver Intelligent Commercialization™ – seamlessly connecting science, technology, and human expertise to unlock value across every stage of the health and life sciences journey.Â
Mary-Kate, who served as Vice President, Global & Corporate Strategy since 2022, now joins the Executive Team as Chief Strategy & Innovation Officer. In this role, she will lead corporate strategy, innovation, global marketing, and brand development.Â
Since joining Inizio in 2021, following the merger of UDG Healthcare and Huntsworth, Mary-Kate has played a pivotal role in shaping the integrated corporate strategy and aligning strategic priorities across the business. As Chief Strategy & Innovation Officer, she will accelerate our Intelligent Commercialization™ approach – harnessing innovation, strategy realization, and AI-driven transformation, with a focus on:Â
Prior to joining Inizio, Mary-Kate built a tenured career in management consulting, working with executive teams across healthcare, financial services, and government sectors to lead large-scale transformation and growth programs.Â
Gavin McShera, who has served as Inizio’s CIO since 2021, now joins our Executive Team. With three decades of global experience in technology leadership across healthcare, retail, finance, aviation, and the public sector, Gavin continues to oversee our enterprise technology strategy, while playing a broader role in shaping organizational leadership.Â
As CIO, Gavin oversees our enterprise technology strategy, focusing on:Â
Before joining UDG Healthcare in 2021, Gavin served as Group CIO at Applegreen PLC and held roles at Microsoft and as an independent consultant.Â
With these appointments, we reinforce our commitment to being a market-leading, trusted commercialization partner for health and life sciences companies worldwide. At Inizio, we bring together data, technology, and multidisciplinary expertise to simplify complexity, reduce risk, and deliver consistent value across the commercialization journey.Â
Learn more about our leadership team. Â
This content was provided by Inizio
Latest Content from Inizio
We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to...
APAC Director Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their real value to patients, healthcare and society.Watch the video:Â https://bit.ly/2OcOWNu
How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Many of us are familiar with billiard games, where two players compete to be the first to pocket all the balls on the table in a particular order. We recently...
EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Considerations when developing an appropriate pricing strategy in self-pay markets
Living with Diabetes is a study conducted amongst approximately 200 Type 2 (T2D) diabetes patients in Brazil and Mexico. The report will consist of quantitative 30-minute online and qualitative telephone...
Director Mariel Metcalfe shares some key findings from a recent Living with psoriasis study conducted in Europe, which is now available to purchase.Psoriasis is a skin condition but its impact...
Across emerging markets we are seeing a shift towards prevention in healthcare policy, as governments seek to contain spiraling treatment costs.There is a growing, if long overdue, recognition among policy-makers...
Director John Branston discusses the benefits of a mobile approach for evaluating medical conferences year-on-year
